DI TOMMASO, VALERIA
 Distribuzione geografica
Continente #
NA - Nord America 1.208
EU - Europa 986
AS - Asia 696
SA - Sud America 79
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 2.979
Nazione #
US - Stati Uniti d'America 1.201
CN - Cina 286
SG - Singapore 222
UA - Ucraina 172
IE - Irlanda 167
TR - Turchia 125
GB - Regno Unito 119
IT - Italia 111
DE - Germania 103
SE - Svezia 103
FR - Francia 95
BR - Brasile 74
FI - Finlandia 63
IN - India 39
RU - Federazione Russa 25
CZ - Repubblica Ceca 9
HK - Hong Kong 7
CH - Svizzera 6
BE - Belgio 4
CA - Canada 4
EU - Europa 4
IR - Iran 4
AR - Argentina 3
KR - Corea 3
MA - Marocco 3
MX - Messico 3
BD - Bangladesh 2
GR - Grecia 2
PK - Pakistan 2
PL - Polonia 2
ZA - Sudafrica 2
CL - Cile 1
DK - Danimarca 1
EG - Egitto 1
ES - Italia 1
ID - Indonesia 1
IL - Israele 1
IQ - Iraq 1
LT - Lituania 1
MD - Moldavia 1
OM - Oman 1
PH - Filippine 1
RS - Serbia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 2.979
Città #
Jacksonville 237
Chandler 218
Dublin 167
Singapore 160
Southend 106
Nanjing 83
Princeton 82
Ashburn 79
Beijing 67
Izmir 64
The Dalles 54
New York 45
Cambridge 39
Dearborn 37
Altamura 28
Nanchang 28
Wilmington 26
Santa Clara 25
Munich 23
Ann Arbor 20
Shenyang 16
Los Angeles 15
Norwalk 15
Washington 15
Turku 14
Grevenbroich 12
Tianjin 12
Chieti 10
Helsinki 10
Jinan 10
Kunming 10
Torino 8
Brno 7
Camerino 7
Guangzhou 7
Hebei 7
Hong Kong 7
Jiaxing 7
Lanzhou 7
Monmouth Junction 7
São Paulo 7
Boardman 6
Campobasso 6
Falls Church 6
Frankfurt am Main 6
Fribourg 6
Hangzhou 6
Leawood 6
Changsha 5
Ardabil 4
Bologna 4
Brussels 4
Changchun 4
Manchester 4
Montesilvano Marina 4
Palermo 4
Rio de Janeiro 4
San Mateo 4
Augusta 3
Belo Horizonte 3
Borgomanero 3
Charlotte 3
Dallas 3
Ningbo 3
San Vito Chietino 3
Taizhou 3
Teramo 3
Woodbridge 3
Zhengzhou 3
Curitiba 2
Hanover 2
Houston 2
London 2
Mumbai 2
Olomouc 2
Orange 2
Palo Alto 2
Paulínia 2
Pelotas 2
Porto Alegre 2
Roubaix 2
San Francisco 2
Shanghai 2
Tappahannock 2
Aachen 1
Agadir 1
Alcantarilla 1
Almirante Brown 1
Andover 1
Annapolis 1
Antakya 1
Ascoli Piceno 1
Atlanta 1
Baton Rouge 1
Bela Vista de Goiás 1
Belgrade 1
Belém 1
Boa Vista 1
Boksburg 1
Boston 1
Totale 1.960
Nome #
Increasing age at disability milestones among MS patients in the MSBase Registry 105
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 99
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 98
Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center 98
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 91
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 89
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 88
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 87
Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective study 86
Nail loss after teriflunomide treatment: a new potential adverse event 82
JCV-Ab serostatus in MS patients treated with Natalizumab 80
Breastfeeding is not related to postpartum relapses in multiple sclerosis. 79
A difficult pediatric case: ADEM evolving in multiple sclerosis complicated by progressive multifocal leukoencephalopathy after Natalizumab treatment. 79
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 79
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 79
Natalizumab-associated PML-IRIS: the Chieti experience. 78
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 78
Neuropsychological testing and quantitative electroencephalography: a search of neurophysiological markers of cognitive decline in multiple sclerosis 77
Prevalence of JC virus antibodies in human serum and seroconversion rate with first-generation and second generation ELISA: the novel assay improves specificity andsensitivity to detect anti-JC virus antibodies 75
Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study 74
Epidural analgesia and caesarean delivery are not associated with post-partum relapses and disability in MS. 74
Multiphasic Adem or Multiple Sclerosis? Treatement implications. 73
Epidural analgesia and caesarean delivery are not associated with post-partum relapses and disability in MS 73
Patient adherence to and tolerability of self-administered interferon beta-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study 72
Progressive multifocal leukoencephalopathy associated with natalizumab in paediatric multiple sclerosis 72
Treatment discontinuation issues in fingolimod treated patients: the Chieti experience. 71
Atypical presentation of Cadasil a diagnostic challenge 71
Intramedullary Spinal Cord Glioblastoma: An Uncommon Diagnosis 67
Tumor necrosis factor α blockade therapy in a case of resistant primary angiitis of the central nervous system 67
Pregnancy outcomes and disease activity after exposure to natalizumab in patients with multiple sclerosis 66
Pregnancy outcomes and disease activity after exposure to natalizumab in patients with multiple sclerosis 66
Neuropsychological testing and event-related potentials: markers of cognitive impairment in patients with multiple sclerosis 65
Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis 64
Pregnancy and fetal outcomes after Glatiramer acetate exposure in patients with Multiple Sclerosis 63
Increased risk of disability progression after pregnancy in MS patients with active disease 63
Spinal cord injury in a patient with multiple sclerosis (MS) with secondary hydromyelia 55
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs 54
Predictors of post-partum relapses and disability progression in Multiple Sclerosis 54
Stratify-2 Test in the clinical practice: results from a large multicentric italian database 54
Pregnancy does not prevent disease re-activation after natalizumab suspension in patients with multiple sclerosis 54
Totale 2.999
Categoria #
all - tutte 12.880
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.880


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 0 0 0 0 0 2
2020/2021198 40 2 45 0 1 43 1 0 19 12 32 3
2021/2022161 1 3 6 30 6 5 12 13 8 6 25 46
2022/2023545 43 92 28 44 68 110 33 28 67 8 14 10
2023/2024326 16 21 25 11 31 146 40 0 1 7 3 25
2024/2025619 43 68 66 3 7 23 20 34 51 46 135 123
Totale 2.999